OPRM1 and breast carcinoma: In animal models of breast cancer, early administration of morphine did not affect the growth of cancer cells, but morphine administered after cancer progression reduced the survival rate, as morphine directly acts on μ-opioid receptors (MOR) expressed in the tumor, thereby promoting the growth of cancer cells 41.